Acadia Pharmaceuticals ACAD
NASDAQ ACAD
$22.18 -3.25 (-12.78%)
At close: Sep 24, 2026 · 4:00 PM EDT

Acadia Pharmaceuticals (ACAD) EBT Margin (2010 - 2026)

Acadia Pharmaceuticals (ACAD) posted EBT Margin of 15.1% for Q2 2026, up 911.89% on a QoQ basis from 1.49% in Q1 2026, and down 10.0% year-over-year from 16.78% in Q2 2025.

Analysis

Acadia Pharmaceuticals (ACAD) EBT Margin (2010 - 2026) Analysis & Trends

Acadia Pharmaceuticals has reported EBT Margin for 17 years, with the latest figure at 15.1% in Q2 2026.

  • On a quarterly basis, EBT Margin fell 10.0% year-over-year to 15.1% in Q2 2026; TTM through Jun 2026 was 10.66%, a 1563.0% decrease from a year earlier, with the FY2025 full-year figure at 12.96%, down 1398.0% from the prior year.
  • EBT Margin was 15.1% for Q2 2026 at Acadia Pharmaceuticals, up from 1.49% in the prior quarter.
  • The five-year high for EBT Margin was 62.05% in Q4 2024, with the low at 97.52% in Q1 2022.
  • Average EBT Margin over 5 years is 2.37%, with a median of 9.73% recorded in 2024.
  • The sharpest annual moves came in 2023 and 2025: EBT Margin soared 5958 bps in 2023, then sank 5278 bps in 2025.
  • Over 5 years, EBT Margin stood at 29.92% in 2022, then soared by 157 bps to 17.18% in 2023, then soared by 261 bps to 62.05% in 2024, then tumbled by 85 bps to 9.26% in 2025, then jumped by 63 bps to 15.1% in 2026.
  • The last three EBT Margin figures came in at 15.1% (Q2 2026), 1.49% (Q1 2026), and 9.26% (Q4 2025), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBT Margin (Qtr)
1 Johnson & Johnson 649.01 Bn 628.25 Bn 17.26 Bn 26.66%
2 AbbVie 468.55 Bn 462.03 Bn 12.70 Bn 25.18%
3 Merck 365.49 Bn 358.40 Bn 12.21 Bn -4.11%
4 Novartis Ag 272.39 Bn 265.10 Bn 11.24 Bn 29.63%
5 Astrazeneca 253.18 Bn 247.96 Bn 12.86 Bn 18.19%
6 Amgen 219.53 Bn 205.54 Bn 7.24 Bn 27.53%
7 Gilead Sciences 187.85 Bn 184.59 Bn 6.22 Bn -131.41%
8 Pfizer 160.56 Bn 149.16 Bn 10.94 Bn -4.34%
9 Vertex Pharmaceuticals 130.81 Bn 122.96 Bn 2.84 Bn 41.75%
10 Acadia Pharmaceuticals 4.38 Bn 3.42 Bn 279.64 Mn 15.10%
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 15.10%
Mar 31, 2026 1.49%
Dec 31, 2025 9.26%
Sep 30, 2025 16.01%
Jun 30, 2025 15.20%
Mar 31, 2025 11.38%
Dec 31, 2024 62.05%
Sep 30, 2024 15.50%
Jun 30, 2024 15.37%
Mar 31, 2024 10.20%
Dec 31, 2023 17.18%
Sep 30, 2023 -24.63%
Jun 30, 2023 3.84%
Mar 31, 2023 -37.94%
Dec 31, 2022 -29.92%
Sep 30, 2022 -20.21%
Jun 30, 2022 -24.97%
Mar 31, 2022 -97.52%
Dec 31, 2021 -32.81%
Sep 30, 2021 -11.24%
API Access

Acadia Pharmaceuticals EBT Margin API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=ebt-margin&ticker=ACAD&period=max&api_key=YOUR_API_KEY